Improved detection sensitivity and characterization – with Ultrasound

eSie Touch elasticity imaging

Our unique eSie Touch™ elasticity imaging is a new method that utilizes a real-time, dual imaging mode to demonstrate the simultaneous display of the standard B-mode image (composition of tissue) and the elastogram (relative stiffness) side-by-side. eSie Touch elasticity imaging is performed with a standard, high-frequency linear transducer and allows clinicians to see a new, different type of ultrasound data. The mechanical properties of tissue provide additional information enabling increased diagnostic findings and confidence. Clinical studies indicate that elasticity imaging has the potential to increase specificity in the evaluation and determination of focal breast lesions.

Fatty Tissue Imaging

Ultrasound techniques have historically used a fixed speed of sound for all imaging, despite the fact that the speed of sound varies in different types of tissue. Siemens Fatty Tissue Imaging technology uses an optimal speed-of-sound adaptation for fatty breast tissue which corrects for phase aberration, thus increasing detail and contrast resolution, and improving boundary detection. The results are better detection and identification of subtle lesion characteristics leading to increased diagnostic confidence. Fatty Tissue Imaging is a real-time, easy-to-use, single-button solution, which is applied during the standard ultrasound exam and requires no additional time to complete the study.

Cadence™ contrast pulse sequencing technology (CPS)*

Contrast pulse sequencing demonstrates the vascularity of lesions and can be used as an aid in determining and monitoring treatment. This technology enables display of the tissue-only image, contrast agent-only image or both from the same acquisition dataset and additionally increases diagnostic confidence when evaluating breast lesions for angiogenesis.

*At the time of publication, the US Food and Drug Administration cleared ultrasound contrast agents for use in LVO only. Check the current regulation for the country in which you are using the technology for contrast agent clearance.

“Initial research in the area indicates that elasticity technology has high specificity for the characterization of breast lesions. The technique is a software modification of a routine ultrasound exam, yet with no noticeable difference to the patient, while still offering diagnostic advantages to both the physician and the patient.”

Richard G. Barr, MD, Professor of Radiology, Northeastern Ohio University College of Medicine, Youngstown, Ohio, USA